Posted by Michael Wonder on 01 Jul 2024
Leqembi (lecanemab) for the treatment of Alzheimer’s disease launched in China
27 June 2024 - China is the third country to launch Leqembi following the United States and Japan.
Eisai and Biogen announced today that the humanised anti-soluble aggregated amyloid-beta monoclonal antibody Leqembi (lecanemab) has been launched in China.
